Ginkgo Bioworks Holdings, Inc. (DNA) closed at $10.02 in the latest trading session, marking a -6.36% move from the prior day ...

BOSTON, Jan. 13, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that Co-Founder and CEO Jason Kelly is ...

Ginkgo Bioworks (NYSE: DNA) stock has had a rough 12 months, falling 88%, and undergoing a reverse stock split on Aug. 20 that left its shares down by around 18% in the aftermath. Depending on which ...

Ginkgo's share price remains under pressure, despite the business stabilizing in Q2. Ginkgo's shift away from downstream value sharing has undermined the company's bull case, which could be hard for ...

Protein large language model (LLM) designed to help enterprises accelerate drug development coming to Google Cloud's Vertex AI Model Garden soon; one of the first-of-its-kind in the industry Model API ...

Which of Ginkgo's bad news was worse? I suspect the Ark Invest sales of Ginkgo stock worried investors more than the company's staffing cuts. Ginkgo announced in its first-quarter update on May 9 that ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.85 in the latest trading session, marking a +2.39% move from the prior day. The stock's change was more than the S&P 500's daily loss of 0.53%. At the ...

BOSTON, Oct. 31, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to advance research and development of ...

Jason Kelly, CEO of Ginkgo Bioworks: "I'm excited to see how the community builds on top of these models and our API. AA-0 is the first model we have released trained on Ginkgo's proprietary data – we ...